The MPO−463G>A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case–Control Studies

Jun-Ping Yang; Wen-Bo Wang; Xiao-Xi Yang; Lei Yang; Li Ren; Fu-Xiang Zhou; Liu Hu; Wei He; Bai-Yu Li; Yan Zhu; Huan-Gang Jiang; Yun-Feng Zhou

doi:10.1371/journal.pone.0065778

Loading metrics

Open Access

Peer-reviewed

Research Article

The MPO−463G>A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case–Control Studies

Jun-Ping Yang ,

Contributed equally to this work with: Jun-Ping Yang, Wen-Bo Wang, Xiao-Xi Yang

Affiliation Department of Radiotherapy Oncology, The Third Affiliated Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Wen-Bo Wang ,

Contributed equally to this work with: Jun-Ping Yang, Wen-Bo Wang, Xiao-Xi Yang

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Xiao-Xi Yang ,

Contributed equally to this work with: Jun-Ping Yang, Wen-Bo Wang, Xiao-Xi Yang

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Lei Yang,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Li Ren,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Fu-Xiang Zhou,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Liu Hu,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Wei He,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Bai-Yu Li,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Yan Zhu,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Huan-Gang Jiang,

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯
Yun-Feng Zhou

* E-mail: yfzhouwhu@163.com

Affiliation Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China
⨯

The MPO−463G>A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case–Control Studies

Jun-Ping Yang,
Wen-Bo Wang,
Xiao-Xi Yang,
Lei Yang,
Li Ren,
Fu-Xiang Zhou,
Liu Hu,
Wei He,
Bai-Yu Li,
Yan Zhu

Published: June 20, 2013
https://doi.org/10.1371/journal.pone.0065778

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Ethnicities
Is the Subject Area "Ethnicities" applicable to this article?

Thanks for your feedback.
Smoking habits
Is the Subject Area "Smoking habits" applicable to this article?

Thanks for your feedback.
Reactive oxygen species
Is the Subject Area "Reactive oxygen species" applicable to this article?

Thanks for your feedback.
Publication ethics
Is the Subject Area "Publication ethics" applicable to this article?

Thanks for your feedback.
Enzymes
Is the Subject Area "Enzymes" applicable to this article?

Thanks for your feedback.